[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100468963":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":114,"collaborators":10,"id":116,"slug":10,"hasResults":117,"nctId":118,"briefTitle":119,"officialTitle":119,"acronym":10,"eligibilityCriteria":120,"healthyVolunteers":117,"sex":121,"minAge":122,"maxAge":123,"enrollmentInfo":124,"targetDuration":127,"studyType":128,"phases":10,"briefSummary":129,"conditions":130,"keywords":132,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":143},{"fullName":5,"class":6},"InSightec","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Exablate",null,"Observational study of Exablate treatment.",[13],"Device: Body System - Functional",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Body System - Functional","MR-Guided Focused Ultrasound",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Nadir Alikacem","CONTACT","+12146302000","nadira@insightec.com",[27,49,65,82,93,103],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"UCLA","RECRUITING","Los Angeles","California","90095","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-118.24368,34.05223,{"lat":39,"lon":38},[42,46],{"name":43,"role":23,"phone":44,"phoneExt":10,"email":45},"Polly Kay, RN, CCRP","310-794-0376","pkay@mednet.ucla.edu",{"name":47,"role":48,"phone":10,"phoneExt":10,"email":10},"Steve Raman, MD","PRINCIPAL_INVESTIGATOR",{"facility":50,"status":29,"city":51,"state":31,"zip":52,"country":33,"countryCode":34,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Stanford University","Stanford","94305",{"type":36,"coordinates":54},[55,56],-122.16608,37.42411,{"lat":56,"lon":55},[59,63],{"name":60,"role":23,"phone":61,"phoneExt":10,"email":62},"Caroline Huang","650-725-6409","chuang99@stanford.edu",{"name":64,"role":48,"phone":10,"phoneExt":10,"email":10},"Pejman Ghanouni, MD, PhD",{"facility":66,"status":29,"city":67,"state":68,"zip":69,"country":33,"countryCode":34,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Mayo Clinic","Rochester","Minnesota","55905",{"type":36,"coordinates":71},[72,73],-92.4699,44.02163,{"lat":73,"lon":72},[76,80],{"name":77,"role":23,"phone":78,"phoneExt":10,"email":79},"Brittany Yaklich","507-538-7765","FOCUSEDULTRASOUND@mayo.edu",{"name":81,"role":48,"phone":10,"phoneExt":10,"email":10},"Gina Hesley, MD",{"facility":83,"status":84,"city":85,"state":10,"zip":10,"country":86,"countryCode":87,"cosmosGeoPoint":88,"geoPoint":92,"contacts":10},"Huashan Hospital Affiliated to Fudan University","ACTIVE_NOT_RECRUITING","Shanghai","China","CN",{"type":36,"coordinates":89},[90,91],121.45806,31.22222,{"lat":91,"lon":90},{"facility":94,"status":29,"city":85,"state":10,"zip":10,"country":86,"countryCode":87,"cosmosGeoPoint":95,"geoPoint":97,"contacts":98},"Shanghai No. 1 Hospital",{"type":36,"coordinates":96},[90,91],{"lat":91,"lon":90},[99],{"name":100,"role":23,"phone":101,"phoneExt":10,"email":102},"Han Wang, MD","+86 181 2128 9109","13564112852@163.com",{"facility":104,"status":29,"city":85,"state":10,"zip":10,"country":86,"countryCode":87,"cosmosGeoPoint":105,"geoPoint":107,"contacts":108},"Shanghai No.1 Hospital",{"type":36,"coordinates":106},[90,91],{"lat":91,"lon":90},[109,113],{"name":110,"role":23,"phone":111,"phoneExt":10,"email":112},"Na Tang","18901807566","tnwaipodaren@126.com",{"name":100,"role":48,"phone":10,"phoneExt":10,"email":10},{"type":115,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100468963",false,"NCT05386615","Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids","Inclusion Criteria: - - Eligibility is as per the symptomatic fibroids device indication. - All registry-consented patients following the treatment of their fibroid(s) with the Exablate system. Exclusion Criteria: -","FEMALE","18 Years","50 Years",{"count":125,"type":126},200,"ESTIMATED","2 Years","OBSERVATIONAL","The goal of this Registry Study is to capture clinical pregnancy outcomes and fibroid treatment background data for any subject post-Exablate treatment for their symptomatic fibroids.",[131],"Uterine Fibroid",[133,9],"Uterine Fibroids","2025-04-29",{"date":136,"type":137},"2025-04-30","ACTUAL",{"date":139,"type":137},"2016-02-16",{"date":141,"type":126},"2026-12-31",{"name":5,"class":6},6]